Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
UCB |
---|---|
Information provided by: | UCB |
ClinicalTrials.gov Identifier: | NCT00552305 |
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.
Condition | Intervention | Phase |
---|---|---|
Partial Epilepsies |
Drug: lacosamide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Open-Label Extension Trial to Determine Tolerability and Efficacy of Long-Term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures |
Estimated Enrollment: | 500 |
Study Start Date: | August 2001 |
Estimated Study Completion Date: | April 2010 |
Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Up to 800mg/day lacosamide (flexible dosing)
|
Drug: lacosamide
50mg and 100mg tablets up to 800 mg/day as bid dosing throughout the trial
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study Director: | UCB Clinical Trial Call Center | +1 877 822 9493 (UCB) |
Responsible Party: | UCB ( Study Director ) |
Study ID Numbers: | SP615 |
Study First Received: | October 30, 2007 |
Last Updated: | October 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00552305 |
Health Authority: | United States: Food and Drug Administration; Germany: Federal Institute for Drugs and Medical Devices; Hungary: National Institute of Pharmacy; Lithuania: State Medicine Control Agency - Ministry of Health; Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products; Sweden: Medical Products Agency; United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Epilepsies, Partial Epilepsy Seizures Central Nervous System Diseases Brain Diseases |
Nervous System Diseases |